View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AP26 Publication ID: Fall 2008 
Title: Medicaid Program: Multiple Source Drugs Definition (CMS-2238-F) 
Abstract: On July 17, 2007, we published a final with comment period in the Federal Register that implemented provisions of the Deficit Reduction Act of 2005 pertaining to prescription drugs under the Medicaid program. In that rule, we finalized certain provisions of the Medicaid drug rebate program, including definitions concerning average manufacturer price, best price, single source drug, and multiple source drug. This rule finalizes the interim final rule with comment period published on March 14, 2008 which revised the definition of “multiple source drug” to better conform with the statutory provisions. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 42 CFR 447.502   
Legal Authority: DRA 2005   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  03/14/2008  73 FR 13785   
Interim Final Rule Comment Period End  04/14/2008    
Interim Final Rule Effective  04/14/2008    
Final Action  10/07/2008  73 FR 54891   
Final Action Effective  12/19/2008    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Gail Sexton
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-4583
Email: gail.sexton@cms.hhs.gov